- Home
- COEP
as 11-05-2025 11:33am EST
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Upcoming Earnings Alert:
Get ready for potential market movements as Coeptis Therapeutics Holdings Inc. COEP prepares to release earnings report on 10 Nov 2025.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WEXFORD |
| Market Cap: | 72.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 34.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.31 - $19.19 | Next Earning Date: | 11-10-2025 |
| Revenue: | $263,555 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Coeptis Therapeutics Holdings Inc. News
COEP Breaking Stock News: Dive into COEP Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 months ago
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
MT Newswires
6 months ago
Coeptis Therapeutics Subsidiary to Merge With Dogecoin Mining Company
GlobeNewswire
8 months ago
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
GlobeNewswire
8 months ago
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
GlobeNewswire
9 months ago
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Insider Monkey
9 months ago
Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation
GlobeNewswire
9 months ago
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups
Insider Monkey
9 months ago
Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations
Compare COEP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COEP Coeptis Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.